Clinical immunity to malaria involves epigenetic reprogramming of innate immune cells
PNAS Nexus · 05.08.2024 · 3 (8)
DOI: 10.1093/pnasnexus/pgae325 ↗Kurz gefasst
Fachartikel in der Zeitschrift PNAS Nexus, online erschienen am 06.08.2024. Verfasst von Jason Nideffer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Stanford University, Stanford, CA 94305, USA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The regulation of inflammation is a critical aspect of disease tolerance and naturally acquired clinical immunity to malaria. Here, we demonstrate using RNA sequencing and epigenetic landscape profiling by cytometry by time-of-flight, that the regulation of inflammatory pathways during asymptomatic parasitemia occurs downstream of pathogen sensing—at the epigenetic level. The abundance of certain epigenetic markers (methylation of H3K27 and dimethylation of arginine residues) and decreased prevalence of histone variant H3.3 correlated with suppressed cytokine responses among monocytes of Ugandan children. Such an epigenetic signature was observed across diverse immune cell populations and not only characterized active asymptomatic parasitemia but also correlated with future long-term disease tolerance and clinical immunity when observed in uninfected children. Pseudotime analyses revealed a potential trajectory of epigenetic change that correlated with a child's age and recent parasite exposure and paralleled the acquisition of clinical immunity. Thus, our data support a model whereby exposure to Plasmodium falciparum induces epigenetic changes that regulate excessive inflammation and contribute to naturally acquire clinical immunity to malaria.
Autor:innen und Institutionen
- Department of Medicine, Stanford University, Stanford, CA 94305, USA.
- Infectious Diseases Research Collaboration, Kampala, Uganda.
- Institute for Immunity, Infection, and Transplantation, Stanford University, Stanford, CA 94305, USA.
- Department of Medicine, University of California, San Francisco, CA 94142, USA.
- School of Medicine, Makerere University, Kampala, Uganda.
- Department of Pediatrics, University of California, San Francisco, CA 94142, USA.
ORCID-Profile: Jason Nideffer, Rek John, Richard Kajubi, Xuhuai Ji, Kenneth Musinguzi, Kathleen Dantzler Press, Nora Yang, Kylie Camanag, Moses Kamya, Margaret E Feeney, Grant Dorsey, Purvesh Khatri, Prasanna Jagannathan
Förderung
- NIAID NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- Bill and Melinda Gates Foundation
- Stanford Center for Human Systems Immunology
Zitieren
APA
Nideffer, J., Ty, M., Donato, M., John, R., Kajubi, R., Ji, X., Nankya, F., Musinguzi, K., Press, K. D., Yang, N., Camanag, K., Greenhouse, B., Kamya, M., Feeney, M. E., Dorsey, G., Utz, P. J., Pulendran, B., Khatri, P., & Jagannathan, P. (2024). Clinical immunity to malaria involves epigenetic reprogramming of innate immune cells. PNAS Nexus, 3(8). https://doi.org/10.1093/pnasnexus/pgae325
Vancouver
Nideffer J, Ty M, Donato M, John R, Kajubi R, Ji X, et al. Clinical immunity to malaria involves epigenetic reprogramming of innate immune cells. PNAS Nexus. 2024;3(8). doi:10.1093/pnasnexus/pgae325
BibTeX
@article{Nideffer2024,
author = {Nideffer, Jason and Ty, Maureen and Donato, Michele and John, Rek and Kajubi, Richard and Ji, Xuhuai and Nankya, Felistas and Musinguzi, Kenneth and Press, Kathleen Dantzler and Yang, Nora and Camanag, Kylie and Greenhouse, Bryan and Kamya, Moses and Feeney, Margaret E and Dorsey, Grant and Utz, Paul J and Pulendran, Bali and Khatri, Purvesh and Jagannathan, Prasanna},
title = {Clinical immunity to malaria involves epigenetic reprogramming of innate immune cells},
journal = {PNAS Nexus},
year = {2024},
volume = {3},
number = {8},
doi = {10.1093/pnasnexus/pgae325}
}
EUVIMED